# PACLITAXEL
> **NDA211875** · New Drug Application · Sponsor: AM REGENT · Approved 2022-07-27
## Drug
- **FDA Application Number:** NDA211875
- **Application type:** New Drug Application
- **Brand name:** PACLITAXEL
- **Generic name:** PACLITAXEL
- **Active ingredients:** PACLITAXEL
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** AM REGENT
- **Manufacturer:** American Regent, Inc.
- **First approval:** 2022-07-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211875)
---
*MORVS · CC0 1.0*